Insights

Key Personnel Moves Carmot Therapeutics has made strategic hires in executive positions like CEO and CMO, indicating a focus on leadership excellence and potentially presenting an opportunity for partnership discussions or collaborations.

Recent Funding Success With a recent Series D financing of $160M, Carmot Therapeutics has showcased strong investor confidence in its innovative drug discovery platform. This funding can be leveraged to explore new business opportunities or expand market reach.

Expanded Therapeutic Programs By developing a broad pipeline of therapeutics targeting obesity and diabetes, including clinical candidates CT-388, CT-868, and CT-996, Carmot Therapeutics has positioned itself as a key player in the metabolic disease space, presenting potential collaboration opportunities with complementary businesses.

Acquisition by Roche Group Carmot Therapeutics being acquired by Roche in early 2024 is a significant development that can open doors for synergies with other Roche subsidiaries or partnerships within the larger Roche Group ecosystem, offering new avenues for sales growth and expansion.

Market Trends Alignment Given the increasing demand for disease-modifying therapies in metabolic diseases and cancer, Carmot Therapeutics' focus on such therapeutics aligns well with current market trends. Leveraging this trend alignment, the company can explore partnerships or collaborations to capitalize on market demand.

Carmot Therapeutics, Inc. Tech Stack

Carmot Therapeutics, Inc. uses 8 technology products and services including WordPress, Twitter Emoji (Twemoji), Google Font API, and more. Explore Carmot Therapeutics, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Google Font API
    Font Scripts
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Yoast SEO
    Search Engines
  • Endurance Page Cache
    Web Platform Extensions
  • Nginx
    Web Servers

Media & News

Carmot Therapeutics, Inc.'s Email Address Formats

Carmot Therapeutics, Inc. uses at least 2 format(s):
Carmot Therapeutics, Inc. Email FormatsExamplePercentage
FLast@carmot.usJDoe@carmot.us
55%
First.Last@carmot.usJohn.Doe@carmot.us
45%

Frequently Asked Questions

Where is Carmot Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Carmot Therapeutics, Inc.'s main headquarters is located at Berkeley, US. The company has employees across 2 continents, including North AmericaEurope.

What is Carmot Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Carmot Therapeutics, Inc. is a publicly traded company; the company's stock symbol is CRMO.

What is Carmot Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Carmot Therapeutics, Inc.'s official website is carmot-therapeutics.us and has social profiles on LinkedIn.

How much revenue does Carmot Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of February 2025, Carmot Therapeutics, Inc.'s annual revenue reached $3.8M.

What is Carmot Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Carmot Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Carmot Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2025, Carmot Therapeutics, Inc. has approximately 13 employees across 2 continents, including North AmericaEurope. Key team members include Head Of Biostatistics, Sr. Dir: J. W.Sr, Vp Regulatory And Quality: D. S.Senior Director, Head Of Medicinal Chemistry: D. M.. Explore Carmot Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Carmot Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Carmot Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Carmot Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Carmot Therapeutics, Inc.'s tech stack includes WordPressTwitter Emoji (Twemoji)Google Font APIRSSOpen GraphYoast SEOEndurance Page CacheNginx.

What is Carmot Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Carmot Therapeutics, Inc.'s email format typically follows the pattern of . Find more Carmot Therapeutics, Inc. email formats with LeadIQ.

How much funding has Carmot Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2025, Carmot Therapeutics, Inc. has raised $150M in funding. The last funding round occurred on May 25, 2023 for $150M.
Carmot Therapeutics, Inc.

Carmot Therapeutics, Inc.

Biotechnology ResearchBerkeley, United States11-50 Employees

Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group. Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes. We are utilizing Chemotype Evolution, a pioneering drug discovery platform, to identify novel incretin receptor signaling targets to develop a broad pipeline of therapeutics that have the potential to produce significant weight loss and improved glycemic control. We have three clinical candidates: CT-388, CT-868 and CT-996.

Section iconCompany Overview

Headquarters
Berkeley, US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CRMO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $150M

    Carmot Therapeutics, Inc. has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on May 25, 2023 in the amount of $150M.

  • $10M

    Carmot Therapeutics, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $150M

    Carmot Therapeutics, Inc. has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on May 25, 2023 in the amount of $150M.

  • $10M

    Carmot Therapeutics, Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.